China
· Delayed Price · Currency is CNY Guangzhou Wondfo Biotech Co.,Ltd Statistics
Total Valuation
Guangzhou Wondfo Biotech Co.,Ltd has a market cap or net worth of CNY 11.55 billion. The enterprise value is 9.96 billion.
| Market Cap | 11.55B |
| Enterprise Value | 9.96B |
Important Dates
The next estimated earnings date is Friday, October 25, 2024.
| Earnings Date | Oct 25, 2024 |
| Ex-Dividend Date | Jun 5, 2024 |
Share Statistics
Guangzhou Wondfo Biotech Co.,Ltd has 477.87 million shares outstanding. The number of shares has increased by 2.29% in one year.
| Shares Outstanding | 477.87M |
| Shares Change (YoY) | +2.29% |
| Shares Change (QoQ) | +4.75% |
| Owned by Insiders (%) | 31.12% |
| Owned by Institutions (%) | 14.40% |
| Float | 271.24M |
Valuation Ratios
The trailing PE ratio is 21.42 and the forward PE ratio is 15.54.
| PE Ratio | 21.42 |
| Forward PE | 15.54 |
| PS Ratio | 3.82 |
| PB Ratio | 2.10 |
| P/FCF Ratio | 50.14 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 14.48, with an EV/FCF ratio of 43.25.
| EV / Earnings | 19.57 |
| EV / Sales | 3.49 |
| EV / EBITDA | 14.48 |
| EV / EBIT | 20.87 |
| EV / FCF | 43.25 |
Financial Position
The company has a current ratio of 7.49, with a Debt / Equity ratio of 0.11.
| Current Ratio | 7.49 |
| Quick Ratio | 6.54 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.90 |
| Debt / FCF | 2.70 |
| Interest Coverage | 15.96 |
Financial Efficiency
Return on equity (ROE) is 10.08% and return on invested capital (ROIC) is 5.23%.
| Return on Equity (ROE) | 10.08% |
| Return on Assets (ROA) | 4.77% |
| Return on Capital (ROIC) | 5.23% |
| Revenue Per Employee | 837,698 |
| Profits Per Employee | 149,507 |
| Employee Count | 3,404 |
| Asset Turnover | 0.46 |
| Inventory Turnover | 2.56 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -1.07% in the last 52 weeks. The beta is 0.67, so Guangzhou Wondfo Biotech Co.,Ltd's price volatility has been lower than the market average.
| Beta (5Y) | 0.67 |
| 52-Week Price Change | -1.07% |
| 50-Day Moving Average | 22.54 |
| 200-Day Moving Average | 25.81 |
| Relative Strength Index (RSI) | 55.47 |
| Average Volume (20 Days) | 8,008,780 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Guangzhou Wondfo Biotech Co.,Ltd had revenue of CNY 2.85 billion and earned 508.92 million in profits. Earnings per share was 1.13.
| Revenue | 2.85B |
| Gross Profit | 1.79B |
| Operating Income | 477.27M |
| Pretax Income | 559.51M |
| Net Income | 508.92M |
| EBITDA | 663.44M |
| EBIT | 477.27M |
| Earnings Per Share (EPS) | 1.13 |
Balance Sheet
The company has 2.30 billion in cash and 621.73 million in debt, giving a net cash position of 1.68 billion or 3.52 per share.
| Cash & Cash Equivalents | 2.30B |
| Total Debt | 621.73M |
| Net Cash | 1.68B |
| Net Cash Per Share | 3.52 |
| Equity (Book Value) | 5.47B |
| Book Value Per Share | 11.48 |
| Working Capital | 3.18B |
Cash Flow
In the last 12 months, operating cash flow was 623.98 million and capital expenditures -393.72 million, giving a free cash flow of 230.27 million.
| Operating Cash Flow | 623.98M |
| Capital Expenditures | -393.72M |
| Free Cash Flow | 230.27M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 62.84%, with operating and profit margins of 16.74% and 17.85%.
| Gross Margin | 62.84% |
| Operating Margin | 16.74% |
| Pretax Margin | 19.62% |
| Profit Margin | 17.85% |
| EBITDA Margin | 23.27% |
| EBIT Margin | 16.74% |
| FCF Margin | 8.08% |
Dividends & Yields
This stock pays an annual dividend of 0.40, which amounts to a dividend yield of 1.54%.
| Dividend Per Share | 0.40 |
| Dividend Yield | 1.54% |
| Dividend Growth (YoY) | -20.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 38.35% |
| Buyback Yield | -2.29% |
| Shareholder Yield | -0.75% |
| Earnings Yield | 4.67% |
| FCF Yield | 1.99% |
Stock Splits
The last stock split was on May 26, 2021. It was a forward split with a ratio of 1.3.
| Last Split Date | May 26, 2021 |
| Split Type | Forward |
| Split Ratio | 1.3 |
Scores
Guangzhou Wondfo Biotech Co.,Ltd has an Altman Z-Score of 8.05.
| Altman Z-Score | 8.05 |
| Piotroski F-Score | n/a |